Policy Analysis: Life Sciences
Published:

University of Cambridge launches Open Innovation drug discovery initiative with GSK

The University of Cambridge is embarking on a programme of scientific open collaboration with GlaxoSmithKline (GSK) that will involve working alongside GSK scientists and other partner organisations, to advance drug discovery and the development of new medicines.

Researchers will be based at Stevenage Bioscience Catalyst, the UK’s first open innovation bioscience campus, co-located with GSK’s Research and Development centre. This bioscience park provides an independent scientific community allowing scientists to foster relationships across organisations...



Related subjects: Cambridge Enterprise, GlaxoSmithKline, Open Innovation

The 2015 Science|Business Annual Summit
The Science|Business Annual Summit brings together leaders from research, industry and policy to debate current and future trends needed to unleash Europe’s technological potential.
Barcelona - 20 November 2015
The future of manufacturing: Industry 4.0 (Date to be confirmed)
A Science|Business public conference
Brussels - 01 October 2015
The Bioeconomy Challenge: Producing more from less
A Science|Business high-level roundtable
Brussels - 29 September 2015
BIG SCIENCE: What’s It Worth?
The world spends millions a year on telescopes, synchrotrons, colliders, DNA databases and other ‘big science’ projects. What does it get for that money?